Parmax Pharma Open Offer: ₹10.04 Cr
Fedex Securities issued a post-offer advertisement for the open offer of Parmax Pharma Limited. The offer involved acquiring 26% stake at ₹42.80 per share.
- Value
- ₹10.04 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Fedex Securities issued a post-offer advertisement for the open offer of Parmax Pharma Limited. The offer involved acquiring 26% stake at ₹42.80 per share.
Fedex Securities submitted a Letter of Offer for Parmax Pharma Ltd. Acquirers intend to buy 23,46,250 equity shares (26% stake) from public shareholders.
Acquirers launched a ₹10.04 Crore open offer for a 26% stake in Parmax Pharma Limited. This mandatory bid follows significant equity acquisitions through share purchase and preferential allotments.